{"filing":{"accession_number":"0001764046-26-000085","cik":"0001764046","ticker":"CLVT","company_name":"CLARIVATE PLC","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"clvt-20260706.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000085/clvt-20260706.htm"},"events":[{"id":16058,"run_id":14323,"accession_number":"0001764046-26-000085","anchor_item_number":"7.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"Clarivate announced a definitive agreement to divest its Life Sciences \u0026 Healthcare segment to Altaris LLC for $600 million in cash and a seller note. This is a material disposition of a business segment representing a significant portion of the company's operations. The transaction includes customary representations, warranties, and covenants, and is expected to close by year-end 2026, with proceeds earmarked for debt reduction and strategic portfolio rationalization.","company_name":"CLARIVATE PLC","ticker":"CLVT","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":[{"id":14012,"accession_number":"0001764046-26-000085","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Clarivate announced a definitive agreement to divest its Life Sciences \u0026 Healthcare segment to Altaris LLC for $600 million in cash and a seller note. This is a material disposition of a business segment representing a significant portion of the company's operations. The transaction includes customary representations, warranties, and covenants, and is expected to close by year-end 2026, with proceeds earmarked for debt reduction and strategic portfolio rationalization.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-06T10:07:37.719832+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":14012,"accession_number":"0001764046-26-000085","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"Clarivate announced a definitive agreement to divest its Life Sciences \u0026 Healthcare segment to Altaris LLC for $600 million in cash and a seller note. This is a material disposition of a business segment representing a significant portion of the company's operations. The transaction includes customary representations, warranties, and covenants, and is expected to close by year-end 2026, with proceeds earmarked for debt reduction and strategic portfolio rationalization.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-06T10:07:37.719832+00:00","company_name":"CLARIVATE PLC","ticker":"CLVT","filing_date":"2026-07-06"}]}